Table 3 CMap analysis identified potential therapeutic drugs for the H-NUSAP1 group
Rank | Score | Type | Name | Description |
|---|---|---|---|---|
1 | − 99.93 | cp | Palbociclib | CDK inhibitor |
2 | − 99.75 | cp | Purvalanol-a | CDK inhibitor |
3 | − 99.65 | cp | Aminopurvalanol-a | Tyrosine kinase inhibitor |
4 | − 99.61 | cp | Floxuridine | DNA synthesis inhibitor |
5 | − 99.54 | cp | L-690488 | Inositol monophosphatase inhibitor |
6 | − 99.33 | cp | Bisbenzimide | DNA-binding agent |
7 | − 99.19 | cp | JAK3-inhibitor-VI | JAK inhibitor |
8 | − 99.08 | cp | Pyrimethamine | Dihydrofolate reductase inhibitor |
9 | − 99.01 | cp | Selumetinib | MEK inhibitor |
10 | − 99.01 | cp | Teniposide | Topoisomerase inhibitor |